Cardiff Oncology, Inc.
(NASDAQ : TROV)

( )
TROV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
SDCSmileDirectClub, Inc. -0.52%7.600.0%$104.34m
DVADaVita, Inc. -2.50%76.763.2%$85.49m
GHGuardant Health, Inc. 1.10%96.910.0%$84.51m
LHCGLHC Group, Inc. 0.56%164.852.9%$62.12m
CHEChemed Corp. 0.18%478.0510.1%$54.96m
AMEDAmedisys, Inc. 0.11%192.0111.5%$53.18m
NTRANatera, Inc. -0.07%45.471.3%$44.16m
NEONeoGenomics, Inc. 1.29%28.185.7%$38.46m
NVTAInvitae Corp. 4.66%17.522.0%$38.12m
ONEM1Life Healthcare, Inc. 0.32%38.000.0%$33.19m
ACHCAcadia Healthcare Co., Inc. -0.76%27.5227.1%$24.88m
MDMEDNAX, Inc. -2.13%15.1711.1%$21.49m
ENSGThe Ensign Group, Inc. 1.98%43.245.7%$19.10m
TVTYTivity Health, Inc. -3.74%9.789.0%$14.38m
ADUSAddus HomeCare Corp. 1.10%92.981.0%$12.70m

Company Profile

Cardiff Oncology, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan on August 4, 1999 and is headquartered in San Diego, CA.